Adaptin Bio (APTN) Cash & Equivalents (2022 - 2026)
Adaptin Bio's Cash & Equivalents came in at $670,488 for Q2 2026, down 50.4% from $1.35 million a year earlier but up 122.5% from the prior quarter.
Powered by 
Analysis
Adaptin Bio (APTN) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Adaptin Bio's Cash & Equivalents was $459,174.
- Cash & Equivalents carries a three-year compound annual growth rate of 872.0% (FY2022 to FY2025).
- Going back by year, Cash & Equivalents was $34,085 in FY2024 (+617.0%), $4,754 in FY2023 (+850.8%) and $500.00 in FY2022.
- The five-year range for quarterly Cash & Equivalents is $322.00 (Q3 2024) to $2.37 million (Q1 2025).
- Year-over-year, Cash & Equivalents increased in 1 of the last four quarters, with growth averaging 116.0%.
- Business Quant data shows APTN's Cash & Equivalents at $301,309 (Q1 2026), $459,174 (Q4 2025) and $579,089 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Adaptin Bio | 56.76 Mn | 54.75 Mn | - | 670,488.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 670,488.00 |
| Mar 31, 2026 | 301,309.00 |
| Dec 31, 2025 | 459,174.00 |
| Sep 30, 2025 | 579,089.00 |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 34,085.00 |
| Sep 30, 2024 | 322.00 |
| Jun 30, 2024 | 23,776.00 |
| Mar 31, 2024 | 5,059.00 |
| Dec 31, 2023 | 4,754.00 |
| Sep 30, 2023 | 380.00 |
| Dec 31, 2022 | 500.00 |
API Access
Adaptin Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=APTN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "APTN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=APTN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();